New Rhein Healthcare Investors

Philadelphia, Pennsylvania, United StatesFounded 2010

New Rhein Healthcare Investors is a Philadelphia-based venture capital firm that applies a private equity investment approach to life sciences investing, focusing on later-stage, de-risked clinical assets in pharmaceuticals and medical devices.

54% of their portfolio is in Healthcare. They made 2 investments in the last 12 months. Average disclosed round size is $30.5M (across 13 rounds with reported amounts).

Find people at New Rhein Healthcare Investors on Goldilocks AI

Portfolio

Fund Size

—

Top Stage

Series A

Last 12 Mo

Team

Ivan Gergel, MD, MBA

Chief Medical Officer & Managing Partner

Nayan Gregory Parekh, PhD

Founder & Managing Partner

Subhanu Saxena, MBA

Managing Partner

Akhil Akula

Principal

Jonathan Soll

Vice President

Russell Keathley, PhD

Vice President

Lauren Exposito

Investor Relations Associate

Chris Ferris

Head of Investor Relations

Bill Engels

Chief Finance Officer

Clarisa Gonsalves

Executive Administrative Assistant

Megan McDermott

Executive Assistant

Portfolio Breakdown

Stage Distribution

Sector Distribution

Investment Activity

DealsAvg Round Size

Portfolio

13 investments

Company	Round	Amount	Valuation	Date	Role
Butterfly Medical	Series C	$21M	—	May 2026
Alveus Therapeutics Inc	Series A	$37M	—	Feb 2026	lead
Corsair Pharma	Series B	$23M	—	Sep 2023
Theranica	Series C	$45M	—	Aug 2022	lead
NNeuraptive	Unknown	$19.5M	—	Jan 2022
AAmerican Injectables Inc	Unknown	$10M	—	Jan 2020
NNeuraptive	Series A	$11.5M	—	Dec 2018
NNeuraptive Therapeutics, Inc.	Series A	$11.5M	—	Dec 2018
NNeuraptive Therapeutics, Inc.	Series A	$11.5M	—	Jan 2018
NNeuraptive	Seed	$1M	—	Jan 2017
NNeuraptive Therapeutics, Inc.	Seed	$1M	—	Jan 2017
AAlveus	Series A	$197M	—	—
Butterfly Medical	Series B	$7M	—	—